While AnxA5 administration alone following cisplatin treatment can rescue the immunosuppressive effects within the TME (Fig. 2 and Supplementary Fig. 13), cisplatin and AnxA5 treatment is not effective at controlling the growth of tumor and prolonging mouse survival (Figs. 1, 5, and 6). Here, ANXA5 is linked to neoplasm.